<DOC>
	<DOCNO>NCT00999284</DOCNO>
	<brief_summary>ZK 200775 antagonist Î±-Amino-3-hydroxy-5-methyl-4-isoxazolepropionate ( AMPA ) receptor earn attention possible neuroprotective agent cerebral ischemia . Probands receive agent within stroke therapy related Phase I trial report alteration visual perception . In trial , effect ZK 200775 visual system analyze detail . In randomised , placebo-controlled , double-blind study eye vision examine intravenous administration ZK 200775 . The following method apply : clinical examination , visual acuity , ophthalmoscopy , colour vision , rod absolute threshold , central visual field , pattern-reversal visual evoke potential ( pVEP ) , ON-OFF full-field electroretinogram ( ERG ) .</brief_summary>
	<brief_title>Ophthalmologic Examinations After Infusion ZK200775</brief_title>
	<detailed_description />
	<criteria>The participant must voluntary proband Age 55 65 year Body weight must exceed follow value : Body height cm minus 100 = body weight [ kg ] +/ 20 % Male sex Written inform consent Physical examination : Probands must show normal finding without clinical relevance , mental physical health require ; Clinical history : Substantial preexist medical condition Known allergy employ effective component galenic component Medicaments drug Intake systemically locally act drug conflict aim trial influence result ( antipsychotic drug , antidepressant , barbiturate benzodiazepine ) A clinical history hint substance alcohol abuse Nicotine abuse 10 cigarette day Consumption alcoholic beverage day prior examination Extreme physical stress ( sport work ) within 8 day prior examination Blood donation within 2 month prior examination Relevant vaccination stay abroad Special onesided alimentation ( strict vegetarianism , lowcaloric diet ) Simultaneous participation another clinical trial Vital sign ( 3 minute rest ) Blood pressure systolic value &gt; 160 mmHg / diastolic value &gt; 95 mmHg Heart frequency : Values beyond 50100 beat per minute Electrocardiogram abnormal 12channel ECG Laboratory finding Hepatitis antigen ( HBsAG ) , hepatitis Cantibodies positive HIVtest Clinical pharmacology positive drug test clinically relevant abnormality examine parameter Opinion investigator : due scientific personal reason matter compliance safety patient take part trial Opacification optic medium , retinal disease , optic nerve disease , amblyopia color vision defect Status post intraocular surgery ( exception : cataract surgery implantation posterior chamber lens ) , laser coagulation Myopia &gt; 5 diopter , hyperopia &gt; +5 diopter Narrow angle glaucoma</criteria>
	<gender>Male</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>ZK200775 test effect vision healthy probands .</keyword>
</DOC>